NRF2

Angelo Michilli1, Cristian Bassi2,3, Farzaneh Moshiri2

  • 1Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.

PubMed
概括

肝细胞癌 (HCC) 中的索拉芬尼抗性涉及NRF2驱动的代谢变化,促进抗氧化防御和生存. 针对这些NRF2通路可以克服HCC患者的索拉芬尼抗性.